期刊文献+

MDR1 C3435T基因多态性与芬太尼术后镇痛效应的关系 被引量:4

Association between MDR1 C3435T genetic polymorphism and postoperative analgesia of fentanyl
原文传递
导出
摘要 目的探索MDR1C3435T基因多态性与芬太尼术后镇痛效应的关系。方法术后随访患者并记录芬太尼镇痛使用量及不良反应发生情况,采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)技术对129例患者进行基因分型,比较不同基因型间芬太尼镇痛效应的差异。结果 129例患者中CC型51例(39.5%)、CT型57例(44.2%)、TT型21例(16.3%)。CT型、TT型患者24 h芬太尼镇痛使用量显著低于CC型(P<0.05),TT型患者48 h芬太尼镇痛使用量显著低于CC型(P<0.05),CT型与CC型48 h芬太尼镇痛量、不同基因型组间不良反应发生率差异无统计学意义。结论 MDR1C3435T与术后不良反应无相关性,但与芬太尼术后镇痛使用量具有相关性,该基因型可能成为疼痛个体化治疗的参考指标。 AIM To investigative the relationship between MDR1 C3435T genetic pol)anorphism and postoperative analgesia of fentanyl. METIIODS The postoperative analgesic requirement of fentanyl and the adverse drug reactions happened were recorded after operation. Polyrnerase chain reaction-restriction fragment length polymorphism (PCR- RFLP) was used to detect the polymorphism of MDR1 C3435T. The analgesic effect was compared among the several pol)anorphisms of MDR1 C3435T. RESULTS In 129 patients, 51(39.5%), 57(44.2%) and 21(16.3%) were cartiers of CC, CT and TT types, respectively. The 24 h analgesic requirement of patients with CT and Tr types was remarkably higher than that of patients with CC, and the 48 h analgesic requirement of patients with TT type was remark- ably lower than that of patients with CC. There was no association between the 48 h analgesic requirement of patients with CT and CC, also between MDR1 genetic polyTnorphism and postoperative adverse drug reactions. CONCLUSION MDR 1 C3435T genetic polymorphisms are not associated with postoperative adverse drug reactions, but are associated with the analgesic requirement of fentanyl. It probably becomes an indicator of individual therapy on pain.
出处 《中国临床药学杂志》 CAS 2011年第3期129-132,共4页 Chinese Journal of Clinical Pharmacy
关键词 芬太尼 MDR1 C3435T 基因多态性 镇痛 fentanyl MDR 1 C3435T genetic polymorphism analgesia
  • 相关文献

参考文献13

  • 1Ikeda K, Ide S, Hart W, et al. How individual sensitivity to opiates can be predicted by gene analyses [ J ]. Trends Humnacol Sci, 2005, 26 (6) : 311.
  • 2Sveeney PB. Pharmacogenomics and anaesthesia: explaining the variability in response to opiates[J]. Eur J Anaesthesiol,2007,24(3) : 209.
  • 3Wandel C, Kim R, Wood hi, et al. Interaction of morphine, fentanyl, sufentanil,alfentanil, and loperamide with the efflux drug transporter P- glycoprotein[ J]. Anesthesiology, 2002,96 (4) : 913.
  • 4Tababe M, Nag,am N, lnoue K, et al. Expression of P-glyeoprotein in human-placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-lgene[J] .J Phannacol Exp Ther,2001,297(3) : 1137.
  • 5Hayashida M, Nagashima M, Satoh Y, et al. Analgesic requirements after major abdominal surgery are associmed with OPPM1 gene polymorphism genotype and haplotype[ J ]. Pharmacogenomics,2008,9( 11 ) : 1605.
  • 6Hynes D, McCarroll M, Hiesse-Provost O. Analgesic efficacy of parenteral paracetamol (propacetamol) and diclofenac in post-operative orthopaedic pain[J]. Acta Anaesthesiol Scand,2006,50(3) : 374.
  • 7涂向东,江清华,兰风华.三种简易提取全血基因组DNA方法的比较[J].中国实验诊断学,2006,10(3):264-266. 被引量:29
  • 8Li D, Zhang GL, Lou YQ, et al. Genetic polymolphisms in MDR1 and CYP3A5 and MDR1 haplotype in mainland Chinese Han, Uygur and Kazakh ethnic groups[J] .J Cain Pharm Ther,2007,32(1) : 89.
  • 9Park H J, Shinn HK, Ryu SH, et al. Genetic polymorphisms in the ABCB1 gene and the effects of fentanyl in Koreans[ J]. Clin Pharmacol Ther,2007,81(4) : 539.
  • 10Kalvass JC, Maurer TS, Pollack GM. Use of plasma and brain unbound fractions to assess the extent of brain distribution of 34 drugs: comparison of unbound concentlation ratios to in vivo P-glyeoprotein effiux ratios[J] .Drug Metab Dispos,2007,35(4) : 660.

二级参考文献14

  • 1HAMABE W, MAEDA T, FUKAZAWA Y, et al. P-glyeoprotein ATPase activating effect of opioid analgesics and their P-glyeoprotein-dependent antinociception in mice [ J ]. Pharmacol Biochem Behav, 2006, 84(3): 629-636.
  • 2HOFFMEYER S, BURK O, VON RICHTER O, et al. Functional polymorphisms of the human multidrug resistance gene: multiple, sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo[ J ]. Proc Natl Acad Sci USA, 2000, 97(7) : 3473-3478.
  • 3PARK H J, SHINN H K, RYU S H, et al. Genetic polymorphisms in the ABCB1 gene and the effects of fentanyl in Koreans [ J ]. Clin Pharmacol Ther, 2007, 84 (4) : 539-546.
  • 4VAN ASPEREN J, SCHINKEL A H, BEIJNEN J H, et al. Altered pharmacokinetics of vinblastine in mdr1a P-glycoprotein-deficient mice[J]. J Natl Cancer Inst, 1996, 88(14) : 994-999.
  • 5KHARASCH E D, HOFFER C, ALTUNTAS T G, et al. Quinidine as a probe for the role of P-glycoprotein in the intestinal absorption and clinical effects of fentanyl [ J ]. J Clin Pharmacol, 2004, 44 (3) : 224-233.
  • 6DAGENAIS C, GRAFF C L, POLLACK G M. Variable modulation of opioid brain uptake by P-glycoprotein in mice [ J]. Biochem Pharmacol, 2004, 67 ( 2 ) : 269-276.
  • 7QIU X Y, JIA Z, ZHANG M, et al. Association of MDRI, CYP3A4 * 18B, and CYP3 A5 * 3 polymorphisms with cyclosporine pharmacokinetics in Chinese renal transplant recipients [ J]. Eur J Clin Pharmacol, 2008, 64( 11 ) : 1069-1084.
  • 8WANG Y, WANG C, LI J, et al. Effect of genetic polymorphisms of CYP3A5 and MDRI on cyclosporine concentration during the early stage after renal transplantation in Chinese patients co-treated with diltiazem [ J ]. Eur J Clin Pharmacol, 2009, 65 (3) : 239-247.
  • 9张卫,常琰子,阚全程,张莉蓉,路辉,王中玉,储勤军,李治松.CYP3A4 1G基因多态性对病人芬太尼镇痛效应的影响[J].中华麻醉学杂志,2009,29(2):125-128. 被引量:8
  • 10王薇,邵超鹏.全血DNA快速提取及其在HHLA基因分型中的应用[J].深圳医学,1998,11(1):5-7. 被引量:5

共引文献30

同被引文献14

  • 1韦润红,赵国兴,陈疏敏,程志.大剂量甲氨蝶呤治疗儿童急性淋巴细胞白血病耐受性临床研究[J].儿科药学杂志,2006,12(3):12-14. 被引量:18
  • 2Angelini A,Centurione L, Sancilio S,et al. The effect of the plastici- zer diethylhexyl phthalate on transport activity and expression of P - glycoprotein in parental and doxo - resistant human sarcoma cell lines [J]. J Biol Regul Homeost Agents, 2011 ;25:203 -211.
  • 3Jamroziak K, Balcerczak E, Smolewski P, et al. MDR1 ( ABCB1 ) gene polymorpbism C3435T is associated with P - glycoprotein activi- ty in B -cell chronic lymphocytic leukemia [ J ]. Pharmacol Rep, 2006 ; 58:720 - 728.
  • 4Fujita N,Kobayashi R,Takimoto T,et al. Results of the Japan association of childhood leukemia study (JACLS) NHL - 98 protocol for the treatment of B - cell non - hodgkin lymphoma and mature B - cell acute lymphoblastic leukemia in childhood [ J ]. Leuk Lymphoma, 2011 ;52:223 - 229.
  • 5Wang D, Johnson AD, Papp AC, et al. Multidrug resistance polypeptide 1 (MDR1, ABCB1 ) variant 3435C > T affects mRNA stability [ J]. Pharmacogenet Genomics ,2005 ; 15:693 - 704.
  • 6Schmiegelow K. Advances in individual prediction of methotrexate toxicity : a review [ J ]. Br J Haematol, 2009 ; 146:489 - 503.
  • 7Martelli N, Mathieu O, Margueritte G, et al. Methotrexate pharmacokinetics in childhood acute lymphoblastic leukaemia: a prognostic value? [J]. J Clin Pharm Ther,2011 ;36:237 -245.
  • 8袁静静,张卫.阿片类药物与基因多态性[J].国际麻醉学与复苏杂志,2010,31(4):360-363. 被引量:5
  • 9高杨,张桥.GSTM1和CYP2D6基因多态性与肺癌敏感性的关系[J].中国公共卫生,1999,15(6):488-490. 被引量:29
  • 10韩璐,刘洁.CYP2D6基因多态性及对药物代谢的影响[J].中国临床药理学与治疗学,2011,16(1):105-110. 被引量:20

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部